PHASE-I TRIAL OF THE COMBINATION OF 6-METHYLMERCAPTOPURINE RIBOSIDE AND 5-FLUOROURACIL

被引:0
|
作者
WIEMANN, MC
CRABTREE, GW
WEITBERG, AB
SPREMULLI, EN
CUMMINGS, FJ
MURRAY, C
CALABRESI, P
机构
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:113 / 116
页数:4
相关论文
共 50 条
  • [31] BIOCHEMICAL MODULATION OF 5-FLUOROURACIL WITH BREQUINAR - RESULTS OF A PHASE-I STUDY
    BUZAID, AC
    PIZZORNO, G
    MARSH, JC
    RAVIKUMAR, TS
    MURREN, JR
    TODD, M
    STRAIR, RK
    POO, WJ
    HAIT, WN
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (05) : 373 - 378
  • [32] COMBINATION 6-MERCAPTOPURINE AND 6-METHYLMERCAPTOPURINE RIBOSIDE IN THE TREATMENT OF ADULT ACUTE-LEUKEMIA - SOUTHWEST-ONCOLOGY-GROUP STUDY
    HEWLETT, JS
    BODEY, GP
    WILSON, HE
    STUCKEY, WJ
    CANCER TREATMENT REPORTS, 1979, 63 (01): : 156 - 158
  • [33] BASIS OF OBSERVED RESISTANCE OF L1210-LEUKEMIA IN MICE METHOTREXATE, 6-THIOGUANINE, 6-METHYLMERCAPTOPURINE RIBOSIDE, 6-MERCAPTOPURINE, 5-FLUOROURACIL, AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE ADMINISTERED IN DIFFERENT COMBINATIONS
    KIM, K
    BLECHMAN, WJ
    RIDDLE, VGH
    PARDEE, AB
    CANCER RESEARCH, 1981, 41 (11) : 4529 - 4534
  • [34] PHASE-I TRIAL OF 5-FLUOROURACIL AND DIPYRIDAMOLE ADMINISTERED BY 72-HOUR CONCURRENT CONTINUOUS INFUSION
    REMICK, SC
    GREM, JL
    FISCHER, PH
    TUTSCH, KD
    ALBERTI, DB
    NIETING, LM
    TOMBES, MB
    BRUGGINK, J
    WILLSON, JKV
    TRUMP, DL
    CANCER RESEARCH, 1990, 50 (09) : 2667 - 2672
  • [35] 6-methylmercaptopurine riboside, a thiopurine nucleoside with antiviral activity against canine distemper virus in vitro
    Otávio Valério de Carvalho
    Daniele Mendes Félix
    Claudia de Camargo Tozato
    Juliana Lopes Rangel Fietto
    Márcia Rogéria de Almeida
    Gustavo Costa Bressan
    Lindomar José Pena
    Abelardo Silva-Júnior
    Virology Journal, 14
  • [36] METABOLITE SENSITIZATION - POTENTIATION OF GROWTH INHIBITORY EFFECTS OF 6-METHYLMERCAPTOPURINE RIBOSIDE (MMPR) BY GUANINE NUCLEOSIDES
    GRINDEY, GB
    LOWE, JK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 99 - 99
  • [37] Response to 'On the antiviral activity and developmental toxicity of 6-methylmercaptopurine riboside (6MMPr)' and 'Acceleration with the brakes on?'
    de Carvalho, Otavio Valerio
    Felix, Daniele Mendes
    de Oliveira, Ronaldo Nascimento
    Seabra, Gustavo
    Silva Junior, Abelardo
    Pena, Lindomar Jose
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (04) : 515 - 516
  • [38] ALPHA-INTERFERON IN COMBINATION WITH 5-FLUOROURACIL AND LEUCOVORIN IN METASTATIC COLORECTAL-CANCER - A PHASE-I STUDY
    PUNT, CJA
    DEMULDER, PHM
    BURGHOUTS, JTM
    WAGENER, DJT
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (04) : 326 - 328
  • [39] INTERFERENCE OF 6-MERCAPTOPURINE RIBOSIDE, 6-METHYLMERCAPTOPURINE RIBOSIDE AND AZATHIOPRINE WITH MORPHOGENETIC DIFFERENTIATION OF MOUSE EXTREMITIES INVIVO AND IN ORGAN-CULTURE
    NEUBERT, D
    LESSMOLLMANN, U
    HINZ, N
    DILLMANN, I
    FUCHS, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 298 (02) : 93 - 105
  • [40] 5-FLUOROURACIL AND METHOTREXATE ADMINISTERED SIMULTANEOUSLY AS A CONTINUOUS INFUSION - A PHASE-I STUDY
    LOKICH, JJ
    PHILLIPS, D
    GREEN, R
    PAUL, S
    SONNEBORN, H
    ZIPOLI, TE
    CURT, G
    CANCER, 1985, 56 (10) : 2395 - 2398